Skip to main content
Clinical Trials/NL-OMON23239
NL-OMON23239
Completed
Not Applicable

eurodevelopmental outcome after neonatal hypoglycemia: a multi-center randomized controlled trial comparing intensive treatment versus expectant glucose monitoring in 'high risk' newborns.

Academical Medical Center, Amsterdam, The Netherlands0 sites800 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Academical Medical Center, Amsterdam, The Netherlands
Enrollment
800
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Boluyt N, Van Kempen AAMW, Offringa M. Neurodevelopment after neonatal hypoglycemia: a systematic review and design of an optimal future study. Pediatrics. 2006 Jun;117(6):2231-43

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Academical Medical Center, Amsterdam, The Netherlands

Eligibility Criteria

Inclusion Criteria

  • 1\. Infants \>\=35 weeks gestational age and \>\=2000 gram with one of the four major risk factors for neonatal hypoglycemia:
  • a. Small\-for\-gestational\-age infants (SGA, birth\-weight\-for\-gestational\-age b. Large\-for\-gestational\-age infants (LGA, birth\-weight\-for\-gestational\-age \>P90\);
  • c. Near\-term infants 35 0/7 to 36 6/7 weeks gestational age with a birth weight \>2000 gram;
  • d. Infants of diabetic mothers (IDM).
  • Birth\-weight\-for\-gestational\-age is defined according to the growth charts of the Perinatale Registratie Nederland (PRN).

Exclusion Criteria

  • Infants with serious co\-morbidity will be excluded, because their co\-morbidity can also affect neurodevelopment:
  • 1\. Very preterm infants (\<34 6/7 weeks gestational age);
  • 2\. Severe perinatal asphyxia: presence of at least 3 of the next criteria:
  • a. Signs of intrauterine asphyxia, like late decelerations on CTG or meconium stained amniotic fluid
  • b. Arterial umbilical cord pH \<7\.10
  • c. Delayed initiation of spontaneous respirations \>5 minutes after birth
  • d. 5 minute Apgar score \<5;
  • e. Multi\-organ failure;
  • 3\. Severe perinatal infection: requiring support of vital functions (infants without clinical signs of infection who are treated with antibiotics because of suspected perinatal infection can be included);
  • 4\. Respiratory insufficiency requiring respiratory support;

Outcomes

Primary Outcomes

Not specified

Similar Trials